Several brokerages have updated their recommendations and price targets on shares of Halyard Health (NYSE: HYH) in the last few weeks:

  • 10/19/2017 – Halyard Health was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Halyard Health, Inc. is a medical technology company. It is focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company sells surgical and infection prevention products for the operating room. Halyard offers products such as sterilization wraps, face masks, surgical drapes and gowns, closed suction catheters, pain pumps and enteral feeding tubes. It offers a range of medical device solutions including post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems, and enteral feeding tubes. Halyard Health, Inc. is headquartered in Alpharetta, Georgia. “
  • 10/17/2017 – Halyard Health had its “hold” rating reaffirmed by analysts at KeyCorp.
  • 10/10/2017 – Halyard Health was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Halyard Health, Inc. is a medical technology company. It is focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company sells surgical and infection prevention products for the operating room. Halyard offers products such as sterilization wraps, face masks, surgical drapes and gowns, closed suction catheters, pain pumps and enteral feeding tubes. It offers a range of medical device solutions including post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems, and enteral feeding tubes. Halyard Health, Inc. is headquartered in Alpharetta, Georgia. “
  • 10/4/2017 – Halyard Health was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “sell” rating. According to Zacks, “Halyard Health, Inc. is a medical technology company. It is focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company sells surgical and infection prevention products for the operating room. Halyard offers products such as sterilization wraps, face masks, surgical drapes and gowns, closed suction catheters, pain pumps and enteral feeding tubes. It offers a range of medical device solutions including post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems, and enteral feeding tubes. Halyard Health, Inc. is headquartered in Alpharetta, Georgia. “
  • 9/21/2017 – Halyard Health had its “buy” rating reaffirmed by analysts at Stifel Nicolaus. They now have a $45.00 price target on the stock.

Shares of Halyard Health, Inc. (NYSE HYH) opened at 44.35 on Wednesday. Halyard Health, Inc. has a 52-week low of $31.59 and a 52-week high of $46.63. The company’s 50 day moving average price is $45.19 and its 200 day moving average price is $40.83. The stock has a market capitalization of $2.07 billion, a PE ratio of 42.64 and a beta of 1.75.

Halyard Health (NYSE:HYH) last announced its earnings results on Wednesday, August 2nd. The medical instruments supplier reported $0.51 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.37 by $0.14. Halyard Health had a return on equity of 8.29% and a net margin of 3.06%. The company had revenue of $399.20 million for the quarter, compared to analyst estimates of $399.16 million. During the same period in the prior year, the company posted $0.45 EPS. The firm’s quarterly revenue was down .2% compared to the same quarter last year. On average, equities research analysts anticipate that Halyard Health, Inc. will post $1.95 EPS for the current year.

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Receive News & Ratings for Halyard Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.